Open Fracture
11
4
4
3
Key Insights
Highlights
Success Rate
75% trial completion
Clinical Risk Assessment
Based on trial outcomes
Moderate Risk
Score: 42/100
9.1%
1 terminated out of 11 trials
75.0%
-11.5% vs benchmark
55%
6 trials in Phase 3/4
0%
0 of 3 completed with results
Key Signals
Data Visualizations
Phase Distribution
Trial Status
Trial Success Rate
Benchmark: 86.5%
Based on 3 completed trials
Clinical Trials (11)
OCT in Open Fracture and Infected Fracture
Implementation of Vancomycin Powder Application in the Emergency Department for Open Fractures
Assessment of Severe Extremity Wound Bioburden at the Time of Definitive Wound Closure or Coverage
Volume Reduction for Open Fracture Irrigation
Placement of Antibiotic Powder in Wounds During the Emergency Room
Powdered Intrawound Vancomycin in Open Fractures Trial
Evaluation of STIMULAN Device and AI Model in Preventing Fracture Infections
Septic Management and Outcome of Open Fracture
Noninferiority Comparison of Prophylactic Open Fracture Antimicrobial Regimens
Preventing Infections in Orthopaedic Patients
Efficacy of DBM on Fractures of the Shinbone (Tibia)